Virtus LifeSci Biotech Products ETF (BBP)

NYSEARCA: BBP · IEX Real-Time Price · USD
49.48
+0.59 (1.21%)
Mar 31, 2023, 12:12 PM EDT - Market open
Assets $17.11M
Expense Ratio 0.79%
PE Ratio n/a
Shares Out 350,000
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
Payout Ratio n/a
1-Year Return +13.27%
Volume 352
Open 49.50
Previous Close 48.89
Day's Range 49.37 - 49.50
52-Week Low 34.12
52-Week High 53.06
Beta 0.74
Holdings 60
Inception Date Dec 17, 2014

About BBP

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus Investment Partners.

Asset Class Equity
Category Health
Region North America
Stock Exchange NYSEARCA
Ticker Symbol BBP
Index Tracked LifeSci Biotechnology Products

Top 10 Holdings

27.80% of assets
Name Symbol Weight
Provention Bio, Inc. PRVB 4.41%
Aurinia Pharmaceuticals Inc. AUPH 4.28%
BridgeBio Pharma, Inc. BBIO 3.26%
Seagen Inc. SGEN 2.72%
Mirum Pharmaceuticals, Inc. MIRM 2.30%
Apellis Pharmaceuticals, Inc. APLS 2.23%
Travere Therapeutics, Inc. TVTX 2.20%
PTC Therapeutics, Inc. PTCT 2.16%
ACADIA Pharmaceuticals Inc. ACAD 2.13%
Exelixis, Inc. EXEL 2.10%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 20, 2017 $0.0723 Dec 27, 2017
Dec 21, 2015 $0.39725 Dec 29, 2015
Full Dividend History

News

5 Least-Hurt Biotech ETFs of the Last Week

Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.

Other symbols: BBHFBTIBBPBE
1 month ago - Zacks Investment Research

2 Sector ETFs Hovering Around a 52-Week High

We all know that Wall Street is shattered this year. Still, two sectors -- Biotech and Aerospace -- have recently hit a 52-week high.

Other symbols: FTXH
4 months ago - Zacks Investment Research

5 Best Areas of Q3 of 2022 & Their Top ETFs

These ETF areas won in the third quarter of 2022.

Other symbols: BBCEWZSMLPAQCLNSMINURA
6 months ago - Zacks Investment Research

Biotech & Crypto -- Best ETF Areas of Last Week

Biotech and cryptocurrency -- two ETF areas outperformed last week.

8 months ago - Zacks Investment Research

Biotech Wins Last Week: 5 Best ETFs

The biotech corner of the broad healthcare sector outperformed last week on speculation over a takeover bid for Global Blood Therapeutics.

Other symbols: BBCPFESBIOXBI
8 months ago - Zacks Investment Research

Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal

Biotechnology sector-related exchange traded funds continued to rally Friday on reports that Pfizer Inc. (NYSE: PFE) is looking to acquire Global Blood Therapeutics (NasdaqGS: GBT). On Friday, the Vir...

Other symbols: SBIOXBI
8 months ago - ETF Trends

Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics

Global Blood Therapeutics (NasdaqGS: GBT) shares climbed Thursday, lifting biotechnology sector-related exchange traded funds, on speculation of takeover bids for the small drug developer. On Thursday...

Other symbols: SBIOXBI
8 months ago - ETF Trends

5 ETFs Riding High on the Biotech Comeback

Biotech, the downtrodden segment of the market, has made a solid comeback on bargain hunting.

Other symbols: BBCCNCRSBIOXBI
9 months ago - Zacks Investment Research

Biotech ETFs Are Making a Comeback

Biotechnology stocks and sector-related exchange traded funds have been gaining momentum as investors return to this downtrodden segment of the market. Over the past month, the Virtus LifeSci Biotech ...

Other symbols: BBCSBIOXBI
9 months ago - ETF Trends

Biotech ETFs That Outperformed Last Week

Biotech ETFs was the biggest gainer last week.

1 year ago - Zacks Investment Research

Healthcare Emerges as Best Sector of Last Week: 5 Top ETFs

Wall Street was downbeat last week with all indexes in the red. Still, Healthcare sector emerged as a key winner last week.

Other symbols: FBTGERMPBESBIO
1 year ago - Zacks Investment Research

Beyond Clean Energy, 5 Sector ETFs Soaring to Record Highs

As most corners of the market rallied on the slew of positive news, a few sectors scaled new highs. We have highlighted five ETFs from different sectors that hit all-time highs in the recent trading s...

Other symbols: ITBPRNXRTXSD
2 years ago - Zacks Investment Research

4 ETFs to Play the Hot Events of Q4

The S&P 500 posted its best third-quarter gains since 2010 with an advancement of 8.5%. The gains could continue as the October-December period is normally gainful for the market.

Other symbols: CLOUONLNPBW
2 years ago - Zacks Investment Research

Top-Performing ETFs of the Worst September Since 2011

After a superb August, September turned gloomy for Wall Street.

Other symbols: DXJSIPOTAN
2 years ago - Zacks Investment Research

5 ETFs Shining Bright Amid September Selling

The combination of lofty valuation, lack of additional fiscal stimulus package, election uncertainty and rising U.S.-China tensions weighed on investors' sentiment.

Other symbols: BETZEDUTIPOTAN
2 years ago - Zacks Investment Research

"Worst September in 18 Years"? 4 Sector ETFs Surviving Selloffs

After a superb August, September looks gloomy for Wall Street. Still,

Other symbols: BETZPBDRTM
2 years ago - Zacks Investment Research

Late-stage biotech ETFs rally Monday on virus treatment hopes

Late-stage biotech exchange-traded funds were among the day's biggest gainers Monday as investors pinned their hopes on medical responses to the novel coronavirus. The ALPS Medical Breakthroughs ETF ...

Other symbols: SBIO
2 years ago - Market Watch

A Guide to Biotech ETF Investing

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

3 years ago - Zacks Investment Research

Biotech ETFs Surge on a Flurry of Positive News

The biotech sector got a boost over the past week from a flurry of positive news including trial results and deal activities.

Other symbols: BBCBTECHEPASBIO
3 years ago - Zacks Investment Research

ACADIA Pharmaceuticals Help Lift Biotech ETFs

While the rest of the biotechnology sector remained depressed along with the broader markets, related exchange traded funds found strength from an unexpected surge in ACADIA Pharmaceuticals (NasdaqGS:...

Other symbols: FBTIBBSBIO
3 years ago - ETF Trends

Biotechnology Market on a Tear: 5 ETFs in Spotlight

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

Other symbols: ARKGBTECSBIOXBI
4 years ago - Zacks Investment Research

A Spread of Top-Ranked ETFs That Crushed the Market in Q1

We are presenting a bunch of top performing ETFs of the first quarter with a solid Zacks ETF Rank #1 or 2 which are expected to outperform in the quarter ahead.

4 years ago - Zacks Investment Research